By irradiating targets in the world-class OPAL research reactor, a diverse set of radioisotopes, primarily for nuclear medicine, are available for a variety of applications and for research.
|Radioisotope||Half life||Emission type||Application|
|Cobalt-57||271.8 days||(EC), γ||Tracing|
|Copper-64||12.7 hours||β+, β-||PET imaging|
|Gallium-67||3.26 days||(EC), γ||SPECT imaging|
|Gallium-68||68.3 minutes||β+||PET imaging|
|Holmium-166||26.8 hours||β-, γ||Therapy|
|Indium-111||2.8 days||(EC), γ||SPECT imaging|
|Iodine-123||13.2 hours||(EC), γ||SPECT imaging|
|Iodine-124||4.2 days||β+||PET imaging|
|Iodine-131||8.02 days||β-, γ||Therapy|
|Lutetium-177||6.65 days||β-, γ||SPECT imaging/therapy|
|Samarium-153||46.3 hours||β-, γ||Therapy|
|Scandium-47||3.35 days||β-, γ||Therapy|
|Technetium-99m||6.01 hours||γ||SPECT imaging|
|Terbium-161||6.9 days||β-, γ||Therapy|
|Yttrium-86||14.74 hours||β+||PET imaging|
|Zirconium-89||3.3 days||β+||PET imaging|
To complement this suite of emerging, noncommercially available OPAL-produced radioisotopes, we are working to extend this range by accessing.
- ANSTO commercial
- National partner cyclotrons
- Imports from international commercial radioisotope vendors
- Imports from collaborative international research reactors and accelerators
The availability of these radioisotopes will differ significantly depending on reactor and cyclotron scheduling and demand for non-routine custom irradiated products.
Fundamental to this capability, ANSTO provides well-equipped, licensed facilities and highly trained staff to handle SPECT-, PET- and therapeutically relevant radionuclides.
ANSTO also operates the National Research Cyclotron Facility providing fluorine-18 and carbon-11 for research.
Please confirm the availability of your selected radioisotope with your ANSTO contact before submitting your proposal.